Videos de Experimentos Relacionados
Una mirada microbiológica a los estudios urodinámicos.
S R Payne1, A G Timoney, S T McKenning
1Department of Urology, St Mary's Hospital, Portsmouth.
Lancet (London, England)
|November 12, 1988
Resumen
Videos de Conceptos Relacionados
También podría leer
Artículos Relacionados
Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.
Ordenar por
Same author
Health-related quality of life in patients with gastrointestinal stromal tumor: data from a real-world cohort compared with a normative population.
ESMO real world data and digital oncology·2026
Same author
Health-Related Quality of Life in Patients With a Head and Neck Sarcoma: A Mixed-Methods Study.
Head & neck·2025
Same author
Double burden: financial toxicity in patients with advanced soft tissue sarcoma at the start of first-line palliative chemotherapy: baseline data from the HOLISTIC study.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2025
Same author
Sex differences in patients with gastrointestinal stromal tumours: do they exist and does it affect survival?
ESMO open·2022
Same author
Priorities and preferences of advanced soft tissue sarcoma patients starting palliative chemotherapy: baseline results from the HOLISTIC study.
ESMO open·2021
Same author
Predictive factors for toxicity and survival of second-line sunitinib in advanced gastrointestinal stromal tumours (GIST).
Acta oncologica (Stockholm, Sweden)·2019
Same journal
Assisted dying and the silencing of medicine's next generation.
Lancet (London, England)·2026
Same journal
Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.
Lancet (London, England)·2026
Same journal
Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.
Lancet (London, England)·2026
Same journal
[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.
Lancet (London, England)·2026
Same journal
Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.
Lancet (London, England)·2026